| Full Kor Name | (주)에이프로젠 | Full Eng Name | Aprogen, Inc |
|---|---|---|---|
| Abbr Kor Name | 에이프로젠 | Abbr Eng Name | Aprogen |
| ISIN | KR7007460009 | Issue Code | 007460 |
| Date of Establishment | 1971-11-15 | Listing Approval Date | |
| Telephone | 031-782-3433 | Listing Date | 1995-07-08 |
| Capital(Won) | 11,211,301,000 | Segment | |
| No of Employees | 236 | Industry | Manufacture of Medicaments |
| Closing Month | 12 | Preferred Stock | 0 |
| Major Product | Common Stock | 22,422,602 | |
| English IR Infomation |
https://www.aprogen.com/en/v.do?a=Main | ||
| Item | 2025. 12 (K-IFRS / Annual Report) | |
|---|---|---|
| Income Statement | Sales | 38634626 |
| Operating Profit | -32813523 | |
| Ordinary Profit | -25274194 | |
| Net Inc Current Year | -25379954 | |
| Balance Sheet | Total Assets | 675188360 |
| Total Liabilities | 431373894 | |
| Capital Stock | 164652515 | |
| Total Capital | 243814466 | |
| Statement of Cash Flow | C/F from Operation | 7517381 |
| C/F from Investing | -66284505 | |
| C/F from Financing | 45314528 | |
| Cash Inc/Dec | -13452595 | |